Tomi Rantamäki

Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain

Tomi Rantamäki, Panu Hendolin, Aino Kankaanpää et al. · Neuropsychopharmacology · 2007 · 302 citations · Full text

Molecular Pharmacology, Psychiatry, Medicine +14

Biosynthesis and Intracellular Targeting of the CLN3 Protein Defective in Batten Disease

Irma Järvelä, Markku Sainio, Tomi Rantamäki et al. · Human Molecular Genetics · 1998 · 190 citations · Full text

Cln3 Protein Defective, Batten Disease, Intracellular Targeting +14

Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade

Tomi Rantamäki, Liisa Vesa, Hanna Antila et al. · PLoS ONE · 2011 · 123 citations · Full text

Enhanced BDNF Signaling is Associated with an Antidepressant-like Behavioral Response and Changes in Brain Monoamines

Eija Koponen, Tomi Rantamäki, Vootele Võikar et al. · Cellular and Molecular Neurobiology · 2005 · 122 citations · Full text

Neuropsychology, Psychopathology, Psychoactive Drug +15

The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice

Jesse Lindholm, Henri Autio, Liisa Vesa et al. · Neuropharmacology · 2011 · 102 citations

Molecular Pharmacology, Psychiatry, Neurophysiology +15